EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity

Xuening Liu iD, Zijian Li iD

Basic Research in Cardiology · 2024

DOI: 10.1007/s00395-024-01054-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic Research in Cardiology, 2024. Verfasst von Xuening Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Antineoplastic Agents, Neoplasms, Heart Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 128 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Beijing Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease is the main factor contributing to the global burden of diseases, and the cardiotoxicity caused by anticancer drugs is an essential component that cannot be ignored. With the development of anticancer drugs, the survival period of cancer patients is prolonged; however, the cardiotoxicity caused by anticancer drugs is becoming increasingly prominent. Currently, cardiovascular disease has emerged as the second leading cause of mortality among long-term cancer survivors. Anticancer drug-induced cardiotoxicity has become a frontier and hot topic. The discovery of epigenetics has given the possibility of environmental changes in gene expression, protein synthesis, and traits. It has been found that epigenetics plays a pivotal role in promoting cardiovascular diseases, such as heart failure, coronary heart disease, and hypertension. In recent years, increasing studies have underscored the crucial roles played by epigenetics in anticancer drug-induced cardiotoxicity. Here, we provide a comprehensive overview of the role and mechanisms of epigenetics in anticancer drug-induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticAntineoplastic AgentsNeoplasmsHeart DiseasesHumansCardiotoxicityAnimals

Stichwörter der Autor:innen

Anticancer drugCardio-oncologyCardiotoxicityDoxorubicinEpigenetics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
  • Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. lizijian@bjmu.edu.cn.
  • Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. lizijian@bjmu.edu.cn.
  • Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, NHC Key Laboratory of Cardiovascular Molecul…

ORCID-Profile: Xuening Liu, Zijian Li

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Beijing Municipal Natural Science Foundation
  • medical research management/basic and clinical research unit of metabolic cardiovascular diseases, Chinese Academy of Medical Sciences

Zitieren

APA

Liu, X., & Li, Z. (2024). The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity. Basic Research in Cardiology. https://doi.org/10.1007/s00395-024-01054-0

Vancouver

Liu X, Li Z. The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity. Basic Research in Cardiology. 2024. doi:10.1007/s00395-024-01054-0

BibTeX
@article{Liu2024,
  author = {Liu, Xuening and Li, Zijian},
  title = {The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity},
  journal = {Basic Research in Cardiology},
  year = {2024},
  doi = {10.1007/s00395-024-01054-0}
}
Kostenlos starten →